119 Using a scenario approach to assess for the current and future demand of immunoglobulins 16. Coates JF. Scenario planning. Technological Forecasting and Social Change. 2000;65:115-123. 17. Zorgautoriteit N. 2019. Accessed December 16, 2019. https:// www.nza.nl/zorgsectoren/medisch-specialistische-zorg/registreren- en-declareren-van-geneesmiddelen. 18. In: Sasongko SL, ed. Concerning the Dutch reimbursement scheme for IVIG and an excel sheet: Overview of indications and entitlement to add-on medicines and coagulation factors G standard June 2019 ed2019. 19. Products SP. About. 2021. Accessed June 28, 2021. https://www. plasmaproducts. com/about 20. Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18(1):143. 21. Given LM. The SAGE Encyclopedia of Qualitative Research Methods. Vol 1-2. SAGE; 2008. 22. Austin Z, Sutton J. Qualitative research: getting started. Can J Hosp Pharm. 2014;67:436-440. 23. Saldaña J. The Coding Manual for Qualitative Research. 2nd ed. SAGE Publications; 2013. 24. Nederland Z. Top 100 van geneesmiddelen o.b.v. de vergoeding in 2020. GIPdatabank.nl. Accessed October 28, 2021. https://www. gipdatabank.nl/databank?infotype=g&label=00-totaal&tabel_g_00- totaal=R_45_top100_atclaatst&geg=vg&spec=&item=) 25. MDSAS. NHS Immunoglobulin Database Report 2017–2018. Accessed July 23, 2018. https://igd.mdsas.com/reports/ 26. MDSAS. NHS Immunoglobulin Database Annual Report 2019– 2020. Accessed July 4, 2021. https://igd.mdsas.com/reports/ 27. MDSAS. NHS Immunoglobulin Database Annual Report 2018– 2019. Accessed June 3, 2019. https://igd.mdsas.com/reports/ 28. European Medicines Agency. Guideline clinical investigation human nor- mal immunoglobulin intravenous administration IVIG revision 3; 2018. 29. Wegnelius G, Bremme K, Lindqvist PG. Efficacy of treatment immune thrombocytopenic purpura in pregnancy with corticoste- roids and intravenous immunoglobulin: a prospective follow-up of suggested practice. Blood Coagul Fibrinolysis. 2018;29(2):141-147. 30. van Schaik IN, Bril V, van Geloven N, et al. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol. 2018;17(1):35-46.
RkJQdWJsaXNoZXIy MTk4NDMw